Literature DB >> 26419687

The complexity of the Nrf2 pathway: beyond the antioxidant response.

Ying Huang1, Wenji Li1, Zheng-yuan Su1, Ah-Ng Tony Kong2.   

Abstract

The NF-E2-related factor 2 (Nrf2)-mediated signalling pathway provides living organisms an efficient and pivotal line of defensive to counteract environmental insults and endogenous stressors. Nrf2 coordinates the basal and inducible expression of antioxidant and Phase II detoxification enzymes to adapt to different stress conditions. The stability and cellular distribution of Nrf2 is tightly controlled by its inhibitory binding protein Kelch-like ECH-associated protein 1. Nrf2 signalling is also regulated by posttranslational, transcriptional, translational and epigenetic mechanisms, as well as by other protein partners, including p62, p21 and IQ motif-containing GTPase activating protein 1. Many studies have demonstrated that Nrf2 is a promising target for preventing carcinogenesis and other chronic diseases, including cardiovascular diseases, neurodegenerative diseases and pulmonary injury. However, constitutive activation of Nrf2 in advanced cancer cells may confer drug resistance. Here, we review the molecular mechanisms of Nrf2 signalling, the diverse classes of Nrf2 activators, including bioactive nutrients and other chemicals, and the cellular functions and disease relevance of Nrf2 and discuss the dual role of Nrf2 in different contexts.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activator; Antioxidant; Kelch-like ECH-associated protein 1 (Keap1); NF-E2-related factor 2 (Nrf2); Nutrients; ROS

Mesh:

Substances:

Year:  2015        PMID: 26419687      PMCID: PMC4785809          DOI: 10.1016/j.jnutbio.2015.08.001

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  246 in total

1.  Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.

Authors:  Luisa M Solis; Carmen Behrens; Wenli Dong; Milind Suraokar; Natalie C Ozburn; Cesar A Moran; Alejandro H Corvalan; Shyam Biswal; Stephen G Swisher; B Nebiyou Bekele; John D Minna; David J Stewart; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2010-06-09       Impact factor: 12.531

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  3H-1,2-dithiole-3-thione targets nuclear factor kappaB to block expression of inducible nitric-oxide synthase, prevents hypotension, and improves survival in endotoxemic rats.

Authors:  Asok R Karuri; Yong Huang; Sridevi Bodreddigari; Carrie Hayes Sutter; Bill D Roebuck; Thomas W Kensler; Thomas R Sutter
Journal:  J Pharmacol Exp Ther       Date:  2005-12-21       Impact factor: 4.030

Review 4.  Chemopreventive functions of isothiocyanates.

Authors:  Young-Sam Keum; Woo-Sik Jeong; Ah-Ng Tony Kong
Journal:  Drug News Perspect       Date:  2005-09

5.  Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.

Authors:  Mee-Hyang Kweon; Vaqar Mustafa Adhami; Jeong-Sang Lee; Hasan Mukhtar
Journal:  J Biol Chem       Date:  2006-09-01       Impact factor: 5.157

6.  BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.

Authors:  Manabu Furukawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

7.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Authors:  Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

8.  Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress.

Authors:  Keon Wook Kang; Seung Jin Lee; Jeong Weon Park; Sang Geon Kim
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

9.  Methylation of the KEAP1 gene promoter region in human colorectal cancer.

Authors:  Naoyuki Hanada; Takenori Takahata; Qiliang Zhou; Xulu Ye; Ruowen Sun; Jugoh Itoh; Atsushi Ishiguro; Hiroshi Kijima; Junsei Mimura; Ken Itoh; Shinsaku Fukuda; Yasuo Saijo
Journal:  BMC Cancer       Date:  2012-02-13       Impact factor: 4.430

Review 10.  DNA methylation pattern as important epigenetic criterion in cancer.

Authors:  Mehrdad Ghavifekr Fakhr; Majid Farshdousti Hagh; Dariush Shanehbandi; Behzad Baradaran
Journal:  Genet Res Int       Date:  2013-12-23
View more
  119 in total

1.  Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes.

Authors:  Xiaoyang Yuan; Huijing Huang; Yi Huang; Jinli Wang; Jinhua Yan; Ling Ding; Cuntai Zhang; Le Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

2.  Adipose-specific ablation of Nrf2 transiently delayed high-fat diet-induced obesity by altering glucose, lipid and energy metabolism of male mice.

Authors:  Le Zhang; Kalavathi Dasuri; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 3.  Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation.

Authors:  Masahito Suiko; Katsuhisa Kurogi; Takuyu Hashiguchi; Yoichi Sakakibara; Ming-Cheh Liu
Journal:  Biosci Biotechnol Biochem       Date:  2016-09-21       Impact factor: 2.043

4.  Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes.

Authors:  Deepa Ajit; Agnes Simonyi; Runting Li; Zihong Chen; Mark Hannink; Kevin L Fritsche; Valeri V Mossine; Robert E Smith; Thomas K Dobbs; Rensheng Luo; William R Folk; Zezong Gu; Dennis B Lubahn; Gary A Weisman; Grace Y Sun
Journal:  Neurochem Int       Date:  2016-05-07       Impact factor: 3.921

5.  Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.

Authors:  Ruchika Mittal; Anil Kumar; Dhirendra Pratap Singh; Mahendra Bishnoi; Tapas Chandra Nag
Journal:  Inflammopharmacology       Date:  2017-11-01       Impact factor: 4.473

6.  Nuclear Factor Erythroid 2-Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen.

Authors:  Wenjuan Rui; Yuhong Zou; Joonyong Lee; Shashank Manohar Nambiar; Jingmei Lin; Linjie Zhang; Yan Yang; Guoli Dai
Journal:  J Pharmacol Exp Ther       Date:  2016-05-09       Impact factor: 4.030

7.  Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.

Authors:  Wenji Li; Doug Pung; Zheng-Yuan Su; Yue Guo; Chengyue Zhang; Anne Yuqing Yang; Xi Zheng; Zhi-Yun Du; Kun Zhang; Ah-Ng Kong
Journal:  Chem Res Toxicol       Date:  2016-03-29       Impact factor: 3.739

8.  Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

Authors:  Peng-Cheng Li; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek; Zhijian Duan; Qian-Yu Zhang; Ai-Xi Yu; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2017-10-23       Impact factor: 3.922

9.  Lowering oxidative stress in ghrelin cells stimulates ghrelin secretion.

Authors:  Bharath K Mani; Sherri Osborne-Lawrence; Nathan Metzger; Jeffrey M Zigman
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-06-16       Impact factor: 4.310

10.  CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses.

Authors:  Dan-Dan Liu; Xia Yuan; Shi-Feng Chu; Chen Chen; Qian Ren; Piao Luo; Mei-Yu Lin; Sha-Sha Wang; Tian-Bi Zhu; Qi-di Ai; Ying-da Zang; Dong-Ming Zhang; Xin He; Zhi-Hua Huang; Hong-Shuo Sun; Zhong-Ping Feng; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.